Related Experiment Video
Updated: May 12, 2026

09:26
Transabdominal Ultrasound for Pregnancy Diagnosis in Reeves' Muntjac Deer
Published on: January 7, 2014
Tularemia during pregnancy
1Department of Otorhinolaryngology, Konya Training and Research Hospital, Hacı Şaban Mah. Meram Yeniyol Caddesi No:97, 42040, Meram, Konya, Turkey. nurdoganata@mynet.com
Infection
|April 6, 2013
Summary
Tularemia, a Francisella tularensis infection, rarely affects pregnant women. This review highlights the risks of tularemia during pregnancy, including potential fetal death, emphasizing early detection and treatment.
Area of Science:
- Infectious Diseases
- Maternal-Fetal Medicine
- Microbiology
Background:
- Tularemia is a zoonotic infection caused by Francisella tularensis.
- Few cases of tularemia in pregnant women are documented, with limited understanding of its impact on pregnancy outcomes.
- The risk of adverse pregnancy outcomes associated with tularemia remains unclear.
Purpose of the Study:
- To review the existing literature on tularemia infection during pregnancy.
- To discuss complications and management strategies for tularemia in pregnant patients.
- To present a case study illustrating the severe consequences of tularemia in pregnancy.
Main Methods:
- Literature review of tularemia in pregnancy.
- Case report analysis of a pregnant patient with tularemia.
- Discussion of clinical manifestations, diagnosis, and treatment.
Main Results:
- Only seven cases of tularemia in pregnant women have been reported previously.
- The presented case involved first-trimester tularemia leading to third-trimester intrauterine fetal death.
- Tularemia poses significant risks to both mother and fetus.
Conclusions:
- Tularemia in pregnancy is rare but can have severe consequences, including fetal demise.
- Early diagnosis and prompt treatment are crucial for managing tularemia during pregnancy.
- Further research is needed to fully understand tularemia's impact on pregnancy and optimize management.
More Related Videos
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

